Ticlopidine is an inhibitor of ADP-induced platelet aggregation. It’s:

Questions 213

ATI RN

ATI RN Test Bank

Effects of Pharmacological Treatments on Clients Across a Lifespan Questions

Question 1 of 5

Ticlopidine is an inhibitor of ADP-induced platelet aggregation. It’s:

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 2 of 5

This drug is a selective beta-1 agonist:

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 3 of 5

This drug is a Class IC antiarrhythmic drug:

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 4 of 5

This drug is contraindicated in patients with moderate to severe heart failure:

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 5 of 5

Pick out the sympatholythic drug:

Correct Answer: C

Rationale: Guanethidine is a sympatholytic drug that inhibits norepinephrine release from sympathetic nerve terminals. Labetalol is an alpha- and beta-blocker, Prazosin is an alpha-1 blocker, and Clonidine is a centrally acting alpha-2 agonist, but Guanethidine specifically depletes catecholamines, making it the best fit.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions